Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07550231 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Determining the Optimal Dose of AD-211 in Patients With Osteoarthritis of the Knee

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Addpharma Inc.
28 trials monitored
See 1 trial at risk
The purpose of this study is to determine the optimal dose of AD-211 in patients with osteoarthritis of the knee.
Trial Details
NCT Number NCT07550231
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Osteoarthritis of the Knees
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov